SCHEMBL16259461

SCHEMBL16259461

CCOCCOCCOCCOCc1ccc(COCc2cccc(COCc3ccccc3)n2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.46
KCNH2 Q12809 2/20 0.41
NAAA Q02083 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.38
TDP1 Q9NUW8 1/20 0.38
HRH4 Q9H3N8 1/20 0.38
HRH3 Q9Y5N1 1/20 0.38
MAOA P21397 1/20 0.36
MAOB P27338 1/20 0.36
LTA4H P09960 1/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
NCF1 P14598 1/20 0.36
S1PR3 Q99500 1/20 0.35
ITGB1 P05556 1/20 0.35
ITGA5 P08648 1/20 0.35
LYPLA1 O75608 1/20 0.35
LYPLA2 O95372 1/20 0.35
HSP90AB1 P08238 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16594058 0.83 TSHR (0.58) TSHRNAAAL3MBTL1TDP1HRH4
SCHEMBL6272283 0.83 TSHR (0.58) TSHRNAAAL3MBTL1TDP1HRH4
SCHEMBL16594830 0.83 TSHR (0.58) TSHRNAAAL3MBTL1TDP1HRH4
SCHEMBL16594607 0.83 TSHR (0.58) TSHRNAAAL3MBTL1TDP1HRH4
SCHEMBL16594477 0.83 TSHR (0.58) TSHRNAAAL3MBTL1TDP1HRH4
SCHEMBL29230056 0.82 TSHR (0.68) TSHRNAAAL3MBTL1TDP1HRH4
SCHEMBL27676364 0.82 TSHR (0.61) TSHRNAAAL3MBTL1TDP1HRH4
SCHEMBL13226430 0.82 TSHR (0.61) TSHRNAAAL3MBTL1TDP1HRH4
SCHEMBL31424945 0.79 TSHR (0.52) TSHRNAAAL3MBTL1TDP1HRH4
SCHEMBL4263972 0.76 KCNH2 (0.48) KCNH2HRH4NCF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140350242-A1 PSEUDOROTAXANES, ROTAXANES AND CATENANES FORMED BY METAL IONS TEMPLATING NATIONAL TAIWAN UNIVERSITY (TW) 2014-11-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140350242-A1 PSEUDOROTAXANES, ROTAXANES AND CATENANES FORMED BY METAL IONS TEMPLATING PCNA, TIMCC, SGTA TSHR 1515/4885KCNH2 2381/4885NAAA 3095/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.